<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32152060</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1754-8411</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Disease models &amp; mechanisms</Title><ISOAbbreviation>Dis Model Mech</ISOAbbreviation></Journal><ArticleTitle>Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">dmm042424</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1242/dmm.042424</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's Disease, is a late-onset X-linked progressive neuromuscular disease, which predominantly affects males. The pathological hallmarks of the disease are selective loss of spinal and bulbar motor neurons, accompanied by weakness, atrophy and fasciculations of bulbar and limb muscles. SBMA is caused by a CAG repeat expansion in the gene that encodes the androgen receptor (AR) protein. Disease manifestation is androgen dependent and results principally from a toxic gain of AR function. There are currently no effective treatments for this debilitating disease. It is important to understand the course of the disease in order to target therapeutics to key pathological stages. This is especially relevant in disorders such as SBMA, for which disease can be identified before symptom onset, through family history and genetic testing. To fully characterise the role of muscle in SBMA, we undertook a longitudinal physiological and histological characterisation of disease progression in the AR100 mouse model of SBMA. Our results show that the disease first manifests in skeletal muscle, before any motor neuron degeneration, which only occurs in late-stage disease. These findings reveal that alterations in muscle function, including reduced muscle force and changes in contractile characteristics, are early pathological events in SBMA mice and suggest that muscle-targeted therapeutics may be effective in SBMA.This article has an associated First Person interview with the first author of the paper.</AbstractText><CopyrightInformation>&#xa9; 2020. Published by The Company of Biologists Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Anna L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annan</LastName><ForeName>Leonette</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dick</LastName><ForeName>James R T</ForeName><Initials>JRT</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Spada</LastName><ForeName>Albert R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanna</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UCL MRC International Centre for Genomic Medicine in Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greensmith</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK l.greensmith@ucl.ac.uk b.malik@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Bilal</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3527-0102</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, UK l.greensmith@ucl.ac.uk b.malik@ucl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/S005021/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS100023</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dis Model Mech</MedlineTA><NlmUniqueID>101483332</NlmUniqueID><ISSNLinking>1754-8403</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006614" MajorTopicYN="N">Hindlimb</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009119" MajorTopicYN="Y">Muscle Contraction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018763" MajorTopicYN="N">Muscle Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Androgen receptor</Keyword><Keyword MajorTopicYN="N">Muscle</Keyword><Keyword MajorTopicYN="N">Myopathy</Keyword><Keyword MajorTopicYN="N">Neuromuscular disease</Keyword><Keyword MajorTopicYN="N">SBMA</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy</Keyword></KeywordList><CoiStatement>Competing interestsThe authors declare no competing or financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32152060</ArticleId><ArticleId IdType="pmc">PMC7272358</ArticleId><ArticleId IdType="doi">10.1242/dmm.042424</ArticleId><ArticleId IdType="pii">dmm.042424</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adachi H., Katsuno M., Minamiyama M., Waza M., Sang C., Nakagomi Y., Kobayashi Y., Tanaka F., Doyu M., Inukai A. et al. (2005). Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 128, 659-670. 10.1093/brain/awh381</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh381</ArticleId><ArticleId IdType="pubmed">15659427</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegbuyiro A., Sedighi F., Pilkington A. W. t., Groover S. and Legleiter J. (2017). Proteins containing expanded polyglutamine tracts and neurodegenerative disease. Biochemistry 56, 1199-1217. 10.1021/acs.biochem.6b00936</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.6b00936</ArticleId><ArticleId IdType="pmc">PMC5727916</ArticleId><ArticleId IdType="pubmed">28170216</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N., Watanabe H., Ito M., Banno H., Suzuki K., Katsuno M., Tanaka F., Tamakoshi A. and Sobue G. (2006). Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 129, 1446-1455. 10.1093/brain/awl096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Badders N. M., Korff A., Miranda H. C., Vuppala P. K., Smith R. B., Winborn B. J., Quemin E. R., Sopher B. L., Dearman J., Messing J. et al. (2018). Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat. Med. 24, 427-437. 10.1038/nm.4500</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4500</ArticleId><ArticleId IdType="pmc">PMC5975249</ArticleId><ArticleId IdType="pubmed">29505030</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista R. L., Costa E. M. F., Rodrigues A. S., Gomes N. L., Faria J. A. Jr., Nishi M. Y., Arnhold I. J. P., Domenice S. and Mendonca B. B. (2018). Androgen insensitivity syndrome: a review. Arch. Endocrinol. Metab. 62, 227-235. 10.20945/2359-3997000000031</Citation><ArticleIdList><ArticleId IdType="doi">10.20945/2359-3997000000031</ArticleId><ArticleId IdType="pubmed">29768628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloemberg D. and Quadrilatero J. (2012). Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS ONE 7, e35273 10.1371/journal.pone.0035273</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035273</ArticleId><ArticleId IdType="pmc">PMC3329435</ArticleId><ArticleId IdType="pubmed">22530000</ArticleId></ArticleIdList></Reference><Reference><Citation>Breza M. and Koutsis G. (2018). Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. J. Neurol. 266, 565-573. 10.1007/s00415-018-8968-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8968-7</ArticleId><ArticleId IdType="pubmed">30006721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bros-Facer V., Krull D., Taylor A., Dick J. R. T., Bates S. A., Cleveland M. S., Prinjha R. K. and Greensmith L. (2014). Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Hum. Mol. Genet. 23, 4187-4200. 10.1093/hmg/ddu136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu136</ArticleId><ArticleId IdType="pubmed">24667415</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C. J., Goss S. J., Lubahn D. B., Joseph D. R., Wilson E. M., French F. S. and Willard H. F. (1989). Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am. J. Hum. Genet. 44, 264-269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1715398</ArticleId><ArticleId IdType="pubmed">2563196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E. S., O'Brien C. J., Wang H., Jenkins S. C., Holder L., Lieberman A. P. and Merry D. E. (2004). Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J. Neurosci. 24, 4778-4786. 10.1523/JNEUROSCI.0808-04.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0808-04.2004</ArticleId><ArticleId IdType="pmc">PMC6729468</ArticleId><ArticleId IdType="pubmed">15152038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C. J., Ling S.-C., Guo L. T., Hung G., Tsunemi T., Ly L., Tokunaga S., Lopez E., Sopher B. L., Bennett C. F. et al. (2014a). Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82, 295-307. 10.1016/j.neuron.2014.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C. J., Miranda H. C., Frankowski H., Batlevi Y., Young J. E., Le A., Ivanov N., Sopher B. L., Carromeu C., Muotri A. R. et al. (2014b). Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 17, 1180-1189. 10.1038/nn.3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3787</ArticleId><ArticleId IdType="pmc">PMC4180729</ArticleId><ArticleId IdType="pubmed">25108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist J. R., Oestergaard S. T., Poulsen N. S., Knak K. L., Thomsen C. and Vissing J. (2019). Muscle contractility in spinobulbar muscular atrophy. Sci. Rep. 9, 4680 10.1038/s41598-019-41240-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-41240-y</ArticleId><ArticleId IdType="pmc">PMC6423126</ArticleId><ArticleId IdType="pubmed">30886222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischbeck K. H. (1997). Kennedy disease. J. Inherit. Metab. Dis. 20, 152-158. 10.1023/A:1005344403603</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1005344403603</ArticleId><ArticleId IdType="pubmed">9211187</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida M., Katsuno M., Nakatsuji H., Adachi H., Kondo N., Miyazaki Y., Tohnai G., Ikenaka K., Watanabe H., Yamamoto M. et al. (2014). Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors. Hum. Mol. Genet. 24, 314-329. 10.1093/hmg/ddu445</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu445</ArticleId><ArticleId IdType="pubmed">25168383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B., Novoselov S., Gray A., Cheetham M. E., Margulis B. and Greensmith L. (2008). Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in SOD1 mouse model of ALS. J. Neurochem. 107, 339-350. 10.1111/j.1471-4159.2008.05595.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05595.x</ArticleId><ArticleId IdType="pubmed">18673445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B., Edet-Amana E. and Greensmith L. (2012). Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 13, 378-392. 10.3109/17482968.2012.660953</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.660953</ArticleId><ArticleId IdType="pubmed">22591194</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M. and Sobue G. (2002). Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843-854. 10.1016/S0896-6273(02)00834-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00834-6</ArticleId><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Adachi H., Tanaka F. and Sobue G. (2004). Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives. J. Mol. Med. 82, 298-307. 10.1007/s00109-004-0530-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-004-0530-7</ArticleId><ArticleId IdType="pubmed">15133611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy W. R., Alter M. and Sung J. H. (1968). Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671-680. 10.1212/WNL.18.7.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D., Kalmar B., Dick J. R. T., Riddoch-Contreras J., Burnstock G. and Greensmith L. (2004). Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10, 402-405. 10.1038/nm1021</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1021</ArticleId><ArticleId IdType="pubmed">15034571</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E. and Fischbeck K. H. (1991). Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79. 10.1038/352077a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A. P. and Robins D. M. (2008). The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer. J. Alzheimers Dis. 14, 247-255. 10.3233/JAD-2008-14212</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2008-14212</ArticleId><ArticleId IdType="pmc">PMC2631577</ArticleId><ArticleId IdType="pubmed">18560135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A. P., Yu Z., Murray S., Peralta R., Low A., Guo S., Yu X. X., Cortes C. J., Bennett C. F., Monia B. P. et al. (2014). Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 7, 774-784. 10.1016/j.celrep.2014.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V., Querin G., Ziff O. J., Zampedri L., Martinelli I., Heller C., Foiani M., Bertolin C., Lu C. H., Malik B. et al. (2019). Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology 92, e1205-e1211. 10.1212/WNL.0000000000007097</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007097</ArticleId><ArticleId IdType="pmc">PMC6511101</ArticleId><ArticleId IdType="pubmed">30787165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubahn D. B., Joseph D. R., Sar M., Tan J., Higgs H. N., Larson R. E., French F. S. and Wilson E. M. (1988). The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2, 1265-1275. 10.1210/mend-2-12-1265</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/mend-2-12-1265</ArticleId><ArticleId IdType="pubmed">3216866</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A., Pennuto M., Tezze C., Querin G., D'Ascenzo C., Silani V., Cenacchi G., Scaramozza A., Romito S., Morandi L. et al. (2013). Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol. 126, 109-121. 10.1007/s00401-013-1122-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1122-9</ArticleId><ArticleId IdType="pubmed">23644820</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Nirmalananthan N., Bilsland L. G., La Spada A. R., Hanna M. G., Schiavo G., Gallo J.-M. and Greensmith L. (2011). Absence of disturbed axonal transport in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 20, 1776-1786. 10.1093/hmg/ddr061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr061</ArticleId><ArticleId IdType="pmc">PMC3071673</ArticleId><ArticleId IdType="pubmed">21317158</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Nirmalananthan N., Gray A. L., La Spada A. R., Hanna M. G. and Greensmith L. (2013). Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy. Brain 136, 926-943. 10.1093/brain/aws343</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws343</ArticleId><ArticleId IdType="pmc">PMC3624668</ArticleId><ArticleId IdType="pubmed">23393146</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Devine H., Patani R., La Spada A. R., Hanna M. G. and Greensmith L. (2019). Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci. Rep. 9, 3539 10.1038/s41598-019-40118-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40118-3</ArticleId><ArticleId IdType="pmc">PMC6401132</ArticleId><ArticleId IdType="pubmed">30837566</ArticleId></ArticleIdList></Reference><Reference><Citation>Milioto C., Malena A., Maino E., Polanco M. J., Marchioretti C., Borgia D., Pereira M. G., Blaauw B., Lieberman A. P., Venturini R. et al. (2017). Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci. Rep. 7, 41046 10.1038/srep41046</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41046</ArticleId><ArticleId IdType="pmc">PMC5259768</ArticleId><ArticleId IdType="pubmed">28117338</ArticleId></ArticleIdList></Reference><Reference><Citation>Montague K., Malik B., Gray A. L., La Spada A. R., Hanna M. G., Szabadkai G. and Greensmith L. (2014). Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy. Brain 137, 1894-1906. 10.1093/brain/awu114</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu114</ArticleId><ArticleId IdType="pmc">PMC4065020</ArticleId><ArticleId IdType="pubmed">24898351</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H. L., Cho M. S., Holder L., Liu Y., Tsvetkov A. S., Finkbeiner S. and Merry D. E. (2009). Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 1937-1950. 10.1093/hmg/ddp115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K., Halievski K., Vicente L., Xu Y., Zeolla D., Poort J., Katsuno M., Adachi H., Sobue G., Wiseman R. W. et al. (2015). Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J. Appl. Physiol. 118, 941-952. 10.1152/japplphysiol.00886.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00886.2014</ArticleId><ArticleId IdType="pmc">PMC4385878</ArticleId><ArticleId IdType="pubmed">25663674</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Gliozzi A., Rusmini P., Sau D., Crippa V., Simonini F., Onesto E., Bolzoni E. and Poletti A. (2008). The role of the polyglutamine tract in androgen receptor. J. Steroid Biochem. Mol. Biol. 108, 245-253. 10.1016/j.jsbmb.2007.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2007.09.016</ArticleId><ArticleId IdType="pubmed">17945479</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J. P., Sumner C. J., Fischbeck K. H. et al. (2009). Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63, 316-328. 10.1016/j.neuron.2009.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Poletti A. (2004). The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons. Front. Neuroendocrinol. 25, 1-26. 10.1016/j.yfrne.2004.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2004.03.001</ArticleId><ArticleId IdType="pubmed">15183036</ArticleId></ArticleIdList></Reference><Reference><Citation>Poort J. E., Rheuben M. B., Breedlove S. M. and Jordan C. L. (2016). Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy. Hum. Mol. Genet. 25, 3768-3783. 10.1093/hmg/ddw222</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw222</ArticleId><ArticleId IdType="pmc">PMC5216617</ArticleId><ArticleId IdType="pubmed">27493028</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes L. E., Freeman B. K., Auh S., Kokkinis A. D., La P. A., Chen C., Lehky T. J., Shrader J. A., Levy E. W., Harris-Love M. et al. (2009). Clinical features of spinal and bulbar muscular atrophy. Brain 132, 3242-3251. 10.1093/brain/awp258</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A., Milioto C., Parodi S., Armirotti A., Borgia D., Pellegrini M., Urciuolo A., Molon S., Morbidoni V., Marabita M. et al. (2016). Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 132, 127-144. 10.1007/s00401-016-1550-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Simonini F., Crippa V., Bolzoni E., Onesto E., Cagnin M., Sau D., Ferri N. and Poletti A. (2011). 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol. Dis. 41, 83-95. 10.1016/j.nbd.2010.08.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.08.023</ArticleId><ArticleId IdType="pubmed">20816782</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P., Polanco M. J., Cristofani R., Cicardi M. E., Meroni M., Galbiati M., Piccolella M., Messi E., Giorgetti E., Lieberman A. P. et al. (2015). Aberrant autophagic response in the muscle of a knock-in mouse model of spinal and bulbar muscular atrophy. Sci. Rep. 5, 15174 10.1038/srep15174</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15174</ArticleId><ArticleId IdType="pmc">PMC4614888</ArticleId><ArticleId IdType="pubmed">26490709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp P. S., Dick J. R. T. and Greensmith L. (2005). The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience 130, 897-910. 10.1016/j.neuroscience.2004.09.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2004.09.069</ArticleId><ArticleId IdType="pubmed">15652988</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher B. L., Thomas P. S. Jr., LaFevre-Bernt M. A., Holm I. E., Wilke S. A., Ware C. B., Jin L.-W., Libby R. T., Ellerby L. M. and La Spada A. R. (2004). Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 41, 687-699. 10.1016/S0896-6273(04)00082-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(04)00082-0</ArticleId><ArticleId IdType="pubmed">15003169</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G., D'Ascenzo C., Polo A., Palmieri A., Baggio L., Vergani L., Gellera C., Moretto G., Pegoraro E. and Angelini C. (2008). Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264, 100-105. 10.1016/j.jns.2007.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T. and Kato S. (2002). Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35, 855-864. 10.1016/S0896-6273(02)00875-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00875-9</ArticleId><ArticleId IdType="pubmed">12372281</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas P. S. Jr., Fraley G. S., Damien V., Woodke L. B., Zapata F., Sopher B. L., Plymate S. R. and La Spada A. R. (2006). Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet. 15, 2225-2238. 10.1093/hmg/ddl148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddl148</ArticleId><ArticleId IdType="pubmed">16772330</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott J. L. and Merry D. E. (2002). Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 277, 50855-50859. 10.1074/jbc.M209466200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209466200</ArticleId><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner R. and Holterhus P.-M. (2014). Androgen action. Endocr. Dev. 27, 28-40. 10.1159/000363610</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000363610</ArticleId><ArticleId IdType="pubmed">25247642</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Halievski K., Henley C., Atchison W. D., Katsuno M., Adachi H., Sobue G., Breedlove S. M. and Jordan C. L. (2016). Defects in neuromuscular transmission may underlie motor dysfunction in spinal and bulbar muscular atrophy. J. Neurosci. 36, 5094-5106. 10.1523/JNEUROSCI.3485-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3485-15.2016</ArticleId><ArticleId IdType="pmc">PMC4854970</ArticleId><ArticleId IdType="pubmed">27147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S., Hashizume A., Hijikata Y., Inagaki T., Suzuki K., Kondo N., Kawai K., Noda S., Nakanishi H., Banno H. et al. (2016). Decreased peak expiratory flow associated with muscle fiber-type switching in spinal and bulbar muscular atrophy. PLoS ONE 11, e0168846 10.1371/journal.pone.0168846</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168846</ArticleId><ArticleId IdType="pmc">PMC5179045</ArticleId><ArticleId IdType="pubmed">28005993</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh S., Tsai M.-Y., Xu Q., Mu X.-M., Lardy H., Huang K.-E., Lin H., Yeh S.-D., Altuwaijri S., Zhou X. et al. (2002). Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc. Natl. Acad. Sci. USA 99, 13498-13503. 10.1073/pnas.212474399</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.212474399</ArticleId><ArticleId IdType="pmc">PMC129702</ArticleId><ArticleId IdType="pubmed">12370412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D. M. and Lieberman A. P. (2006). Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 116, 2663-2672. 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773.</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>